Form 8-K - Current report:
SEC Accession No. 0001104659-25-074530
Filing Date
2025-08-06
Accepted
2025-08-06 08:07:17
Documents
14
Period of Report
2025-08-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2522358d1_8k.htm   iXBRL 8-K 36452
2 EXHIBIT 99.1 tm2522358d1_ex99-1.htm EX-99.1 17585
6 GRAPHIC tm2522358d1_ex99-1img001.jpg GRAPHIC 21497
  Complete submission text file 0001104659-25-074530.txt   259365

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxs-20250806.xsd EX-101.SCH 3017
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20250806_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20250806_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2522358d1_8k_htm.xml XML 3686
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 251187568
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)